Picture of Neuronetics logo

STIM Neuronetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Neuronetics Inc reports results for the quarter ended in September - Earnings Summary

* Neuronetics Inc  STIM.OQ  reported a quarterly adjusted
loss
of 28 cents​​ per share for the quarter ended in September. The
mean expectation of five analysts for the quarter was for a loss
of 42 cents per share.
    * Revenue rose 19.6% to $16.50 million from a year ago;
analysts
expected $15.02 million. 
    * Neuronetics Inc's reported EPS for the quarter was a loss
of 28
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Neuronetics Inc shares had risen by 16.4% this quarter and
lost 17.0% so far this year.
    * The company reported a quarterly loss of $7.61 million.
    * Wall Street's median 12-month price target for Neuronetics
Inc
is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 03:14 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.42          -0.28          Beat
 Jun. 30 2022      -0.41          -0.39          Beat
 Mar. 31 2022      -0.40          -0.41          Missed
 Dec. 31 2021      -0.32          -0.29          Beat

Recent news on Neuronetics

See all news